Zymeworks Inc.
ZYME | NASDAQ
$27.57
+$0.76 (+2.83%)
At close: Sep 22, 2026, 4:00 PM ET
$27.57
$0 (-0.02%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Market Data
Market Cap $1.97B
Enterprise Value $-252.72B
Beta 1.19
Average Volume 641.53K
Shares Outstanding (Diluted) 72.99M
Shares Change YoY -5.67%
Institutional Ownership 94.14%
Exchange NASDAQ
ISIN US98985Y1082
Price Performance
Price Change 1M -6.8%
Price Change 3M 12.3%
Price Change 6M 10.7%
Price Change YTD 0.7%
Price Change 1Y 62.2%
Price Change 3Y 318.9%
Price Change 5Y -6.0%
1M CAGR (ann.) 13.9%
1Y CAGR (ann.) 62.6%
5Y CAGR (ann.) -4.3%
All-Time CAGR 8.0%
Valuation
PE Ratio -13.27
Forward PE 15.69
PEG Ratio 0.19
Forward PEG 0.75
PS Ratio 60.62
Forward PS 6.10
PB Ratio 0.02
P/FCF Ratio -11.88
P/Adj. FCF Ratio -10.13
P/OCF Ratio -16.45
EV/Sales -7,767.14
EV/EBIT 2,429.25
EV/EBITDA 5.98
EV/FCF 1,522.64
Earnings Yield -7.5%
FCF Yield -8.4%
Adj. FCF Yield -9.9%
Financial Health
Net Cash $254.69B
Total Debt $16.01B
Cash & Short-Term Investments $270.7B
Total Assets $396.96B
Current Ratio 6.32
Quick Ratio 6.32
Debt / Equity Ratio 3.34
Debt / EBITDA -0.38
Debt / FCF -96.44
OCF / Debt -0.01
Interest Coverage -75.30
Altman Z-Score -4.13
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 87.8%
Operating Profit Margin -129985.5%
EBITDA Margin -376.9%
Net Profit Margin -404.0%
FCF Margin -510.1%
Adj. FCF Margin -598.3%
SBC / Revenue 58.6%
SBC Impact (per share) -17.3%
Returns
Return on Assets -37.8%
Return on Equity -72.1%
Return on Invested Capital -43.7%
Return on Capital Employed -44.5%
Return on Tangible Assets -39.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -58.3%
Revenue CAGR 5Y 9.4%
Revenue CAGR 10Y 15.0%
EPS CAGR 3Y -16.6%
EPS CAGR 5Y 2.6%
EPS CAGR 10Y 6.9%
FCF CAGR 3Y -34.6%
FCF CAGR 5Y -8.5%
FCF CAGR 10Y -8.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 22
EPS Growth Next 3Y 52.0%
Revenue Growth Next 3Y 122.5%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $2.44
EPS Growth Est (next Q) -1038.5%
Revenue Est (next Q) $233.71M
Revenue Growth Est (next Q) 746.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $41
Price Target Upside 52.9%
Cash Flow
Operating Cash Flow $-164.78M
Free Cash Flow $-165.97M
Adj. Free Cash Flow $-194.68M
FCF Per Share -$1.64
OCF Per Share -$1.63
OCF/S Ratio -320.7%
Income Statement
Revenue $32.54M
Gross Profit $28M
Operating Income $-42.29B
EBITDA $-42.28B
Net Income $-45.12B
EPS (Diluted) -$2.02
Revenue / Employee $140.85K
Profit / Employee $-195.34M
Employees 231
Add to Watchlist
Select watchlists to add or remove ZYME